CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia alleviates long COVID symptoms
07.08.2025 - 17:59:58 | prnewswire.co.uk
to download photo of the press release.
en | boerse | 68021079 |
